This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

OncoMed Pharmaceuticals Inc (OMED)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 38.44M 28.14M 208.93M 16.26M
Receivables 70.70M 7.12M 23.00K 4.02M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 231.25M 240.81M 318.74M 71.39M
Property, Plant & Equipment, Gross 21.68M 20.72M 19.67M 19.12M
Accumulated Depreciation & Depletion 16.85M 15.62M 15.03M 13.65M
Property, Plant & Equipment, Net 4.83M 5.10M 4.64M 5.46M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.81M 1.93M 10.30M 2.92M
Total Non-Current Assets 6.63M 7.03M 14.94M 8.38M
Liabilities & Shareholder Equity
Total Assets 237.89M 247.84M 333.69M 79.77M
Accounts Payable 6.66M 4.43M 5.71M 849.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 742.00K 688.00K 11.39M 756.00K
Total Current Liabilities 52.64M 38.55M 62.02M 20.13M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 1.73M 2.47M 3.15M 3.75M
Other Non-Current Liabilities 179.97M 130.46M 150.40M 17.34M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 181.69M 132.93M 153.55M 203.87M
Total Liabilities 234.34M 171.47M 215.56M 224.00M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 3.55M 76.37M 118.12M -144.23M
Common Par 30.00K 30.00K 29.00K 1.00K
Additional Paid In Capital 313.34M 300.79M 292.50M 4.11M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -309.84M -224.44M -174.43M -148.35M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 20.00K -17.00K 14.00K 15.00K
Total Capitalization 3.55M 76.37M 118.12M -144.23M
Total Equity 3.55M 76.37M 118.12M -144.23M
Total Liabilities & Stock Equity 237.89M 247.84M 333.69M 79.77M
Total Common Shares Outstanding 30.12M 29.85M 29.40M 1.11M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 30.03M 29.66M 13.53M 22.22M
Diluted Weighted Shares Outstanding 30.03M 29.66M 13.53M 22.22M
Number of Employees 122 108 91 NA
Number of Part-Time Employees 0 0 0 NA
OMED News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

OMED OncoMed Pharmaceuticals Inc

Chart of OMED

Analysts Ratings for OMED

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 3 3 3
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET OMED ANALYST REPORT

OMED Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs